Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019.
19
CAP
COVID
Canada
acquired pneumonia
community
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
27
09
2021
accepted:
03
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Dealing with coronavirus disease 2019 (COVID-19) has been a monumental test of medical skills and resources worldwide. The management of community-acquired pneumonia (CAP) can at times be difficult, but treating CAP in the setting of COVID-19 can be particularly trying and confusing and raises a number of challenging questions relating to etiology, diagnosis, and treatment. This article is based on the authors' experiences and presents an overview of how CAP during COVID-19 is handled in Canada. We touch on the issues of microbial etiology in patients with CAP in the setting of COVID-19 as well as diagnostic, site of care, and treatment approaches. Published guidelines are the basis of management of CAP and are discussed in the context of Canadian data. We also outline the usual treatment approaches to COVID-19, particularly in patients who have been hospitalized.
Identifiants
pubmed: 35211634
doi: 10.1093/ofid/ofac043
pii: ofac043
pmc: PMC8863085
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofac043Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Lancet. 2021 Sep 4;398(10303):843-855
pubmed: 34388395
Clin Infect Dis. 2019 Oct 15;69(9):1467-1475
pubmed: 30615108
N Engl J Med. 2019 Feb 14;380(7):651-663
pubmed: 30763196
J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii5-vii11
pubmed: 29982570
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
EClinicalMedicine. 2021 Oct;40:101102
pubmed: 34485873
Crit Care. 2019 Mar 27;23(1):99
pubmed: 30917856
Respir Investig. 2020 Nov;58(6):435-436
pubmed: 32967798
Clin Microbiol Infect. 2021 Jan;27(1):61-66
pubmed: 33010444
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
N Engl J Med. 2015 Jun 4;372(23):2185-96
pubmed: 25981908
Chest. 2008 Dec;134(6):1141-1148
pubmed: 18689592
Clin Infect Dis. 2019 Oct 15;69(9):1476-1479
pubmed: 30615129
J Chemother. 2021 May;33(3):174-179
pubmed: 32996844
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
BMC Infect Dis. 2018 Dec 7;18(1):637
pubmed: 30526505
N Engl J Med. 2021 Apr 22;384(16):1491-1502
pubmed: 33631065
JAMA. 2020 Sep 15;324(11):1048-1057
pubmed: 32821939
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
N Engl J Med. 2021 Aug 26;385(9):790-802
pubmed: 34351721
BMJ. 2020 Sep 4;370:m3379
pubmed: 32887691
N Engl J Med. 2021 Apr 22;384(16):1564-1565
pubmed: 33631064
Am J Respir Crit Care Med. 2020 Aug 15;202(4):604-606
pubmed: 32551807
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
N Engl J Med. 2021 Jan 21;384(3):229-237
pubmed: 33113295
Lancet Respir Med. 2021 Jul;9(7):763-772
pubmed: 33844996
J Antimicrob Chemother. 2019 Aug 1;74(Suppl 4):iv5-iv21
pubmed: 31505641
Clin Microbiol Infect. 2013 Mar;19(3):249-56
pubmed: 22404211
JAMA. 2019 Nov 5;322(17):1661-1671
pubmed: 31560372
Lancet Respir Med. 2021 Dec;9(12):1407-1418
pubmed: 34480861
J Antimicrob Chemother. 2019 Mar 1;74(3):645-653
pubmed: 30500898
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
N Engl J Med. 2021 Dec 2;385(23):e81
pubmed: 34587383
Front Cell Infect Microbiol. 2021 Mar 22;11:643326
pubmed: 33828999
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
J Glob Antimicrob Resist. 2021 Mar;24:335-339
pubmed: 33540083
Clin Infect Dis. 2019 Nov 13;69(11):1856-1867
pubmed: 30722059
N Engl J Med. 2021 Mar 4;384(9):795-807
pubmed: 33306283
Clin Infect Dis. 2000 Aug;31(2):383-421
pubmed: 10987698
N Engl J Med. 2021 Aug 26;385(9):777-789
pubmed: 34351722
Clin Infect Dis. 2019 Mar 5;68(6):e1-e47
pubmed: 30566567
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
J Infect Dis. 2020 Sep 14;222(8):1270-1279
pubmed: 32726441
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
Am J Clin Dermatol. 2008;9(4):245-54
pubmed: 18572975
Ann Intern Med. 2020 Aug 18;173(4):304-305
pubmed: 32379883
Lancet Glob Health. 2022 Jan;10(1):e42-e51
pubmed: 34717820
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591